[1] |
Wu Minhang, Sun Wenzheng, Yu Qingzhuo, Guo Rong, Ye Hui, Du Ying, Qiu Jin, An Huazhang, Cao Lili.
RNF43 inhibits PD-L1 expression via β-catenin in melanoma cells and promotes CD8+ T cell-mediated anti-tumor immune reaction
[J]. Journal of International Oncology, 2023, 50(7): 407-412.
|
[2] |
Li Bin, Zhang Guifang, Zhou Linjing, Yang Xiaodong, He Qiuli, Jia Sisi, Huang Puchao, Liang Jiaxin.
Relationships between PIK3CA gene status and clinical features and prognosis in triple-negative breast cancer
[J]. Journal of International Oncology, 2023, 50(5): 263-267.
|
[3] |
Zhang Jingxian, Su Jianfei, Wei Xueqin, Yi Dan, Li Xiaojiang.
Treatment status of non-small cell lung cancer with METexon14 skipping mutation
[J]. Journal of International Oncology, 2023, 50(1): 37-41.
|
[4] |
Hong Anlan, Cao Meng, Wang Yan, Fang Fang.
Research progress on lncRNAs as members of ceRNA network in melanoma
[J]. Journal of International Oncology, 2022, 49(1): 61-64.
|
[5] |
Zhou Ye, Yu Yan.
MET14 exon skipping mutation and non-small cell lung cancer
[J]. Journal of International Oncology, 2021, 48(6): 366-369.
|
[6] |
Zhang Ruizhi, Chen Xin, Zhang Peng, Tao Kaixiong.
New progress on diagnosis and treatment of anorectal malignant melanoma
[J]. Journal of International Oncology, 2020, 47(6): 377-380.
|
[7] |
Du Mingli, Li Guixiang, Wu Wenjuan, Zhao Lei.
Application of circulating tumor DNA in targeted therapy and immunotherapy of metastatic melanoma
[J]. Journal of International Oncology, 2020, 47(6): 381-384.
|
[8] |
Yi Zongbi, Ma Fei, Xu Binghe.
Profile of gene mutations and targeted treatment of brain metastases in breast cancer
[J]. Journal of International Oncology, 2019, 46(6): 354-357.
|
[9] |
Wu Yuanyuan, Wang Jun.
Advancement of targeted agents in the treatment of anaplastic thyroid carcinoma
[J]. Journal of International Oncology, 2019, 46(2): 98-101.
|
[10] |
Hu Wei, Zhang Yu.
Analysis of gene detection status of EGFR mutation in 170 patients with advanced lung adenocarcinoma
[J]. Journal of International Oncology, 2019, 46(1): 11-16.
|
[11] |
Jin Lan, Kang Xiaojing.
Drug resistance mechanism and treatment strategy for targeted therapy of melanoma
[J]. Journal of International Oncology, 2018, 45(7): 444-448.
|
[12] |
Li Lixi, Ma Fei.
Clinicopathological characteristics and susceptibility genes of early-onset breast cancer
[J]. Journal of International Oncology, 2018, 45(4): 241-244.
|
[13] |
Miao Qiuju, Wang Yifei, Xu Xiulian..
Molecular targeted therapy in malignant melanoma
[J]. Journal of International Oncology, 2018, 45(11): 699-702.
|
[14] |
Ma Yi, Xu Shun.
Pulmonary adenocarcinoma shown as groundglass nodule: radiology, histopathology and molecular biology characteristics
[J]. Journal of International Oncology, 2018, 45(10): 627-631.
|
[15] |
Xia Dechun, Kang Xiaojing.
Role and mechanism of Notch signaling pathway in melanoma growth and metastasis
[J]. Journal of International Oncology, 2018, 45(10): 635-638.
|